Marine‐derived n‐3 fatty acids therapy vs No marine‐derived n‐3 fatty acids therapy
Adverse events · stroke and/or TIA
Marine‐derived n‐3 fatty acids therapy showed no clear difference in adverse events compared with no marine‐derived n‐3 fatty acids therapy (low certainty).
2 findings from 1 review
- RR 0.94 [0.56, 1.58]1 study · 1455 participantsLow
- no estimate extracted2 studies · 57 participantsVery low